COMP <GO>
TFX vs JNJ // REVENUE GROWTH (YOY)
Teleflex Incorporated (NYSE) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: TFX 4
— JNJ 11
▲ REVENUE GROWTH (YOY) LEADER: TFX
LAST: $139.77 (-1.15%) • MKT CAP: $5.99B
revenue-growth
17.20%
LAST: $273.20 (-0.73%) • MKT CAP: $662.49B
revenue-growth
6.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TFX VS. JNJ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | TFX | JNJ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 56.20% | 67.90% | -11.70 | JNJ | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 1.80% | 25.50% | -23.70 | JNJ | /roic <GO> |
| EV/EBITDA & P/E Valuation | 40.9x | 18.5x | +22.40 | JNJ | /valuation <GO> |
| Free Cash Flow Yield | -18.00% | 2.97% | -20.97 | JNJ | /fcf-yield <GO> |
| Operating Margin | 5.90% | 34.70% | -28.80 | JNJ | /operating-margins <GO> |
| Net Profit Margin | -45.40% | 28.50% | -73.90 | JNJ | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 17.20% | 6.00% | +11.20 | TFX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.01% | 0.00% | +1.01 | TFX | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.12 | 5.59 | -3.47 | JNJ | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 8/9 | -4.00 | JNJ | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.80% | 7.20% | -0.40 | TFX | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 67.9 | 60.4 | +7.57 | TFX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.98 | 1.08 | -0.10 | JNJ | /macro-sensitivity <GO> |
| Forward P/E Multiple | 27.0x | 23.0x | +4.00 | JNJ | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.99B | $662.49B | -$656.50B | JNJ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | TFX REV | JNJ REV | TFX GROSS % | JNJ GROSS % | TFX FCF | JNJ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.99B | $94.19B | 56.2% | 67.9% | -$1.11B | $19.70B |
| FY 2024 | $1.70B | $88.82B | 61.0% | 69.1% | -$11.9M | $19.84B |
| FY 2023 | $1.71B | $85.16B | 44.0% | 44.0% | $323.4M | $18.96B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TFX // BETA 0.98
JNJ // BETA 1.08